| 2023-12-31 | Stryker Corporation | $4,424 | Long term medical supply or device loan | In-kind items and services | PROCUITY Device, PATIENT HANDLING - PH | | 2023 |
| 2023-12-31 | Stryker Corporation | $1,444 | Long term medical supply or device loan | In-kind items and services | PRIME Device, PATIENT HANDLING - PH | | 2023 |
| 2023-12-31 | Stryker Corporation | $652 | Long term medical supply or device loan | In-kind items and services | ISOTOUR Device, PATIENT CARE - PC | | 2023 |
| 2023-12-31 | Stryker Corporation | $652 | Long term medical supply or device loan | In-kind items and services | ISOTOUR Device, PATIENT CARE - PC | | 2023 |
| 2023-12-31 | Linvatec Corporation | $603 | Long term medical supply or device loan | In-kind items and services | HALL POWER Device, ORTHOPEDIC SURGERY | | 2023 |
| 2023-12-31 | Stryker Corporation | $372 | Long term medical supply or device loan | In-kind items and services | ISOFLEX LAL Device, PATIENT HANDLING - PH | | 2023 |
| 2023-12-31 | Stryker Corporation | $372 | Long term medical supply or device loan | In-kind items and services | ISOFLEX LAL Device, PATIENT HANDLING - PH | | 2023 |
| 2023-11-20 | Edwards Lifesciences Corporation | $24,847 | Research payment | Cash or cash equivalent | | THE ENCIRCLE Trial (#2018-19) | 2023 |
| 2023-11-20 | Edwards Lifesciences Corporation | $2,500 | Research payment | Cash or cash equivalent | | ALLIANCE 2021-05 | 2023 |
| 2023-11-08 | Abbott Laboratories | $15,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ACCENT Device, Cardiac Rhythm Management | | 2023 |
| 2023-11-06 | Edwards Lifesciences Corporation | $11,376 | Research payment | Cash or cash equivalent | | TRISCEND II Pivotal Trial 2020-05 CONTINUED ACCESS STUDY | 2023 |
| 2023-11-02 | Edwards Lifesciences Corporation | $24,440 | Research payment | Cash or cash equivalent | | TRISCEND II Pivotal (2020-05) | 2023 |
| 2023-11-02 | Edwards Lifesciences Corporation | $21,849 | Research payment | Cash or cash equivalent | | CLASP II TR Pivotal, Study No. 2019-07 | 2023 |
| 2023-11-02 | Abbott Laboratories | $5,927 | Research payment | Cash or cash equivalent | MITRACLIP Device, Vascular | Percutaneous MitraClip Device or Surgical Mitral Valve Repair in Patients with PrImary Mitral Regurgitation Who Are Cand | 2023 |
| 2023-11-02 | Edwards Lifesciences Corporation | $500 | Research payment | Cash or cash equivalent | | TRISCEND II Pivotal (2020-05) | 2023 |
| 2023-10-26 | Biosense Webster, Inc. | $15,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | CARTO 3 Device, Cardiology | | 2023 |
| 2023-10-18 | Abbott Laboratories | $7,077 | Research payment | Cash or cash equivalent | AMPLATZER AMULET Device, Structural Heart | Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antago | 2023 |
| 2023-10-17 | Abbott Laboratories | $2,500 | Research payment | Cash or cash equivalent | MITRACLIP Device, Vascular | Percutaneous MitraClip Device or Surgical Mitral Valve Repair in Patients with PrImary Mitral Regurgitation Who Are Cand | 2023 |
| 2023-10-16 | Abbott Laboratories | $1,268 | Research payment | Cash or cash equivalent | FLEXABILITY Device, Electrophysiology | Abbott Ventricular Tachycardia Post Approval Study | 2023 |
| 2023-10-12 | Edwards Lifesciences Corporation | $6,500 | Research payment | Cash or cash equivalent | | TRISCEND II Pivotal (2020-05) | 2023 |
| 2023-10-12 | Edwards Lifesciences Corporation | $2,500 | Research payment | Cash or cash equivalent | | TRISCEND II Pivotal (2020-05) | 2023 |
| 2023-09-28 | Edwards Lifesciences Corporation | $75,257 | Research payment | Cash or cash equivalent | | TRISCEND II Pivotal (2020-05) | 2023 |
| 2023-09-25 | Edwards Lifesciences Corporation | $50 | Research payment | Cash or cash equivalent | | THE ENCIRCLE Trial (#2018-19) | 2023 |
| 2023-09-21 | Abbott Laboratories | $850 | Research payment | Cash or cash equivalent | AMPLATZER AMULET Device, Structural Heart | Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antago | 2023 |
| 2023-09-05 | Edwards Lifesciences Corporation | $6,623 | Research payment | Cash or cash equivalent | | THE ENCIRCLE Trial (#2018-19) | 2023 |
| 2023-08-31 | Edwards Lifesciences Corporation | $37,439 | Research payment | Cash or cash equivalent | | CLASP II TR Pivotal, Study No. 2019-07 | 2023 |
| 2023-08-22 | Abbott Laboratories | $5,059 | Research payment | Cash or cash equivalent | MITRACLIP Device, Vascular | Percutaneous MitraClip Device or Surgical Mitral Valve Repair in Patients with PrImary Mitral Regurgitation Who Are Cand | 2023 |
| 2023-08-16 | Impulse Dynamics (USA) Inc. | $7,500 | Research payment | Cash or cash equivalent | OPTIMIZER Device, Cardiovascular Device | Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) | 2023 |
| 2023-08-08 | Abbott Laboratories | $105 | Research payment | In-kind items and services | MITRACLIP Device, Vascular | Percutaneous MitraClip Device or Surgical Mitral Valve Repair in Patients with PrImary Mitral Regurgitation Who Are Cand | 2023 |
| 2023-08-02 | Abbott Laboratories | $746 | Research payment | Cash or cash equivalent | MITRACLIP Device, Vascular | A Post-Market Study Assessment of the Safety and Performance of the MitraClip G4 System | 2023 |
| 2023-07-27 | Edwards Lifesciences Corporation | $23,495 | Research payment | Cash or cash equivalent | | TRISCEND II Pivotal (2020-05) | 2023 |
| 2023-07-19 | Abbott Laboratories | $5,845 | Research payment | Cash or cash equivalent | AMPLATZER AMULET Device, Structural Heart | Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antago | 2023 |
| 2023-07-10 | Edwards Lifesciences Corporation | $1,000 | Research payment | Cash or cash equivalent | | THE ENCIRCLE Trial (#2018-19) | 2023 |
| 2023-07-03 | Edwards Lifesciences Corporation | $65,793 | Research payment | Cash or cash equivalent | | CLASP II TR Pivotal, Study No. 2019-07 | 2023 |
| 2023-06-26 | Edwards Lifesciences Corporation | $1,000 | Research payment | Cash or cash equivalent | | CLASP II TR Pivotal, Study No. 2019-07 | 2023 |
| 2023-06-26 | Edwards Lifesciences Corporation | $1,000 | Research payment | Cash or cash equivalent | | TRISCEND II Pivotal (2020-05) | 2023 |
| 2023-06-22 | Edwards Lifesciences Corporation | $9,000 | Research payment | Cash or cash equivalent | | CLASP IID 2018-07 | 2023 |
| 2023-06-22 | Edwards Lifesciences Corporation | $2,500 | Research payment | Cash or cash equivalent | | ALLIANCE AVIV 2021-05 | 2023 |
| 2023-06-20 | Abbott Laboratories | $1,000 | Research payment | Cash or cash equivalent | MITRACLIP Device, Vascular | Percutaneous MitraClip Device or Surgical Mitral Valve Repair in Patients with PrImary Mitral Regurgitation Who Are Cand | 2023 |
| 2023-06-15 | Merge Healthcare Incorporated | $227 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | | 2023 |
| 2023-06-13 | Abbott Laboratories | $6,500 | Research payment | Cash or cash equivalent | FLEXABILITY Device, Electrophysiology | Abbott Ventricular Tachycardia Post Approval Study | 2023 |
| 2023-06-05 | Abbott Laboratories | $40 | Research payment | In-kind items and services | FLEXABILITY Device, Electrophysiology | Abbott Ventricular Tachycardia Post Approval Study | 2023 |
| 2023-06-05 | Abbott Laboratories | $30 | Research payment | In-kind items and services | FLEXABILITY Device, Electrophysiology | Abbott Ventricular Tachycardia Post Approval Study | 2023 |
| 2023-05-24 | Abbott Laboratories | $10,627 | Research payment | Cash or cash equivalent | MITRACLIP Device, Vascular | Percutaneous MitraClip Device or Surgical Mitral Valve Repair in Patients with PrImary Mitral Regurgitation Who Are Cand | 2023 |
| 2023-05-10 | Abbott Laboratories | $9,865 | Research payment | Cash or cash equivalent | AMPLATZER AMULET Device, Structural Heart | Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antago | 2023 |
| 2023-05-10 | Abbott Laboratories | $1,566 | Research payment | Cash or cash equivalent | MITRACLIP Device, Vascular | A Post-Market Study Assessment of the Safety and Performance of the MitraClip G4 System | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $424 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-05-04 | Masimo Corporation | $381 | Long term medical supply or device loan | Cash or cash equivalent | SET and rainbow SET Device, CARDIOVASCULAR | | 2023 |
| 2023-04-27 | Edwards Lifesciences Corporation | $6,687 | Research payment | Cash or cash equivalent | | THE ENCIRCLE Trial (#2018-19) | 2023 |
| 2023-04-06 | Edwards Lifesciences Corporation | $7,203 | Research payment | Cash or cash equivalent | | THE ENCIRCLE Trial (#2018-19) | 2023 |
| 2023-04-03 | Edwards Lifesciences Corporation | $7,150 | Research payment | Cash or cash equivalent | | ALLIANCE AVIV 2021-05 | 2023 |
| 2023-03-14 | Linvatec Corporation | $1,356 | Long term medical supply or device loan | In-kind items and services | HALL POWER Device, ORTHOPEDIC SURGERY | | 2023 |
| 2023-03-09 | Edwards Lifesciences Corporation | $3,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve Device, Transcatheter Heart Valves | | 2023 |
| 2023-03-01 | Abbott Laboratories | $455 | Research payment | Cash or cash equivalent | MITRACLIP Device, Vascular | A Post-Market Study Assessment of the Safety and Performance of the MitraClip G4 System | 2023 |
| 2023-02-15 | Abbott Laboratories | $965 | Research payment | Cash or cash equivalent | MITRACLIP Device, Vascular | Percutaneous MitraClip Device or Surgical Mitral Valve Repair in Patients with PrImary Mitral Regurgitation Who Are Cand | 2023 |
| 2023-02-08 | Abbott Laboratories | $6,585 | Research payment | Cash or cash equivalent | AMPLATZER AMULET Device, Structural Heart | Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antago | 2023 |
| 2023-02-08 | Abbott Laboratories | $2,125 | Research payment | Cash or cash equivalent | MITRACLIP Device, Vascular | A Post-Market Study Assessment of the Safety and Performance of the MitraClip G4 System | 2023 |
| 2023-02-07 | Shockwave Medical, Inc | $7,500 | Grant | Cash or cash equivalent | SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER Device, Lithoplasty | | 2023 |
| 2023-02-02 | Abbott Laboratories | $17,500 | Education | Cash or cash equivalent | | | 2023 |
| 2023-01-20 | Siemens Medical Solutions USA, Inc. | $10,000 | Grant | Cash or cash equivalent | | | 2023 |
| 2023-01-17 | Edwards Lifesciences Corporation | $20,000 | Grant | Cash or cash equivalent | | | 2023 |
| 2023-01-10 | Abbott Laboratories | $450 | Research payment | In-kind items and services | AMPLATZER AMULET Device, Structural Heart | Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antago | 2023 |
Comments